Background: Production of Bla OXA-23, OXA-24, OXA-58 and hyperexpression of OXA-51 due to ISAba1 insertion sequence are the leading causes of carbapenem resistance in Acinetobacter baumannii. The loss of OprD transmembrane protein and the overexpression of some effl ux pumps are considered to be the main factors for carbapenem resistance in Pseudomonas aeruginosa whereas metallo-enzymes' production has a secondary role. Aim: Тo examine the carbapenem resistance due to carbapenemase production among clinically signifi cant Gram-negative non-fermenters from St George University hospital, Plovdiv: A. baumannii and P. aeruginosa. Materials and methods: Forty three A. baumannii and 43 P. aeruginosa isolates, resistant or with intermediate resistance to imipenem and/or meropenem were included in the study. They were collected from patients admitted in 14 various hospital wards between 2010 and 2014. Both phenotypic and genetic methods were used for identifi cation and antimicrobial susceptibility testing. Results: All A. baumannii demonstrated carbapenemase production determined by a modifi ed Hodge test whereas P. aeruginosa isolates did not show this phenomenon. OXA-23 genes were determined in 97.7% (42 out of 43) of A. baumannii isolates indistinguishable from the sequence of the classical ARI-1 gene. OXA-24, OXA-58 and overexpression of OXA-51 were not registered in any of the isolates. All P. aeruginosa were negative for blaVIM and blaIMP genes.
Pseudomonas aeruginosa and Acinetobacter baumanii are clinically signifi cant opportunistic human pathogens, which are associated with nosocomial infections worldwide. Infections caused by these bacteria are typically serious and diffi cult for treatment due to their intrinsic and acquired resistance to a great variety of antimicrobials. 1 In the last 20 years a huge number of clinical isolates have been reported to be resistant to the most effective bacte-Folia Medica I 2017 I Vol. 59 I No. 4 ricidal antimicrobial agents such as carbapenems. The two most frequently applied representatives of this group -imipenem and meropenem, are the last line drugs for empirical therapy of severe multi-drug resistant infections. Therefore the resistance against them imposes insuperable therapeutic restrictions.
The main mechanisms of carbapenem resistance in P. aeruginosa are the loss of the outer-membrane OprD protein and the hyperexpression of the effl ux pumps belonging to the Resisto-Nodular Division (RND) such as MexAB-OprM and MexXY-OprM sometimes combined with overexpression of intrinsic AmpC. 2, 3 The production of carbapenem-hydrolizing enzymes as metallo-enzymes especially blaVIM and blaIMP plays a secondary role. 4 On the other hand carbapenemase production in A. baumannii facing class oxacillinases (group 2df beta-lactamases) including OXA-23, OXA-24, OXA-58 and the hyperexpression of OXA-51 is the leading cause of this type of resistance in many cases combined with other mechanisms as impaired infl ux and/or increased effl ux. 5 
AIM
The aim of this study was to examine the structure of carbapenem resistance among P. aeruginosa and A. baumannii clinical isolates from our hospital. This would help us to elucidate the therapeutic options and antibiotic stewardship strategies hence such kind of investigations had never been performed till this moment in the hospital.
MATERIALS AND METHODS

MATERIALS
Forty three P. aeruginosa and 43 A. baumannii clinical isolates collected between 2010 and 2014 from different clinical units of St George University Hospital in Plovdiv were examined in the study (Table 1) . The greatest number of isolates was obtained from the Intensive Care Unit (ICU) following by the Department of Burn Care, Cardiac surgery and Pediatrics. The including criteria were: confi rmed identifi cation, resistance or intermediate susceptibility to imipenem and/or meropenem, different resistance type for isolates from the same unit, precise clinical and epidemiological data. Isolates which didn't match the above criteria were excluded from the study.
METHODS
Both phenotypic and molecular methods were used for identifi cation, screening the presence of carbapenemases and typing.
The identifi cation of all bacterial isolates was confi rmed using VITEK 2 automatic system and API20-NE strip tests (BioMerieux, France) with automatic interpretation performed by BIOMIC V3 (Giles scientifi c, USA). It was followed by PCR detection of the intrinsic OXA-51 (biochemical methods are not reliable in distinguishing A. baumannii from some genomic species). The antibiotic susceptibility to imipenem (10 μg) and meropenem (10 μg), (Liofi lchem) was determined by BauerKurby disk-diffusion test, E-tests with imipenem and meropenem and automatically obtained gradient MIC by VITEK 2 system. The results were assessed on the basis of CLSI criteria which were still in use in our country until 2014.
PHENOTYPIC TESTS FOR CARBAPENEMASE DETECTION
A modifi ed Hodge test (MHT) was used for screening of common carbapenemase production as previously described 6, 7 followed by double-disk combined test with disks imipenem (10 μg) and imipenem/EDTA (10/760 μg), (Liofi lchem), 8 and combined E-test with imipenem (4-256 μg/mL) and imipenem (1-64 μg/mL) + constant level of EDTA (Liofi lchem) for detection of metallo-β-lactamases. 9, 10 MOLECULAR TESTS Omega bio-tek E.Z.N.A Bacterial DNA kit (VWR) was used for DNA extraction of isolates after 18 hours of cultivation on 5% Columbia agar (Biolife). The average concentration of DNA was 22 μg/ml. The amplifi cation process was performed on Applied Biosystems 7300 Real-Time PCR machine. Primers for PCR screening of carbapenemases are listed in Table 2 .
CONVENTIONAL PCR SCREENING FOR CARBAPENEMASE-ENCODING GENES
PCR reactions were carried out in 25 μl volumes containing 1x PCR buffer with 1.5 mM MgCl 2; 0.2 mM dNTP; 1.5 U Taq polymerase (VWR); 3 μl DNA; 50 pmol forward and reverse primer per reaction. PCR conditions included 30 cycles of amplifi cation under the following conditions: denaturing at 95°C (30s); annealing for 60s at primer specifi c temperatures (Table 2) , extension at 72°C (1 min/ kb product) and fi nal extension at 72°C (10 min). PCR products were resolved on 1% agarose gel stained with Gel-Red (Biotium) and photographed under UV light illumination. 100-bp DNA ladder (Biolabs, New England) was used to assess the product size.
RAPD-PCR ANALYSIS
We applied our own experimental RAPD protocol using ERIC 1R-(5'-AAGCCTCCTGGGGATTCA-3') and ERIC 2-(5'AAGTAAGTGACTGGGGT-GAGCG-3') primers 11, 12 which turned out to be applicable to both microorganisms: A. baumannii and P. aeruginosa. Fragments were separated by QiAxcel capillary electrophoresis (Qiagen, Germany) and analyzed by CLIQS 1D PRO software (TotalLab, England).
PCR reactions were carried out in 25 μl volumes containing 1x PCR extra buffer with 1.5 mM MgCl 2 ; 0.2 mM dNTP; 1.5U μl Taq; 4 μl DNA; 100 pmol of ERIC 1R primer and ERIC 2 primer per reaction.
PCR conditions included initial denaturing at 95°C (5 min) followed by 45 cycles of amplifi ca- 
PCR conditions included initial DNA denaturing at 96°C (30s) followed by 35 cycles of amplifi cation (denaturing at 96°C for 20s; annealing at 50°C for 20s and extension at 60°C for 4 min).
STATISTICAL ANALYSIS
To identify the dynamics of carbapenem resistance in A. baumannii and P. aeruginosa isolates Time series analysis and forecasting were applied. Data manipulation and graphical representation as well as descriptive and statistical analyses were undertaken using statistical software package SPSS v.19 (IBM Corp. Chicago, IL, USA).
RESULTS
All A. baumannii and P. aeruginosa isolates exhibited resistance to more than 3 groups of antimicrobials which determined them as multi-drug resistant. Their antibiotic susceptibility pattern is shown in Fig. 1 .
The susceptibility testing to carbapenems revealed 8 different profi les. Thirty six (84%) of A. baumannii isolates and 21 (49%) of P. aeruginosa were resistant to both imipenem and meropenem (Table 3 ). Forty two out of 43 A. baumannii (97.7%) isolates demonstrated positive result for carbapenemase production using MHT (Fig. 3) , whereas all 43 P. aeruginosa isolates were negative for such phenomenon. Neither A. baumannii nor P. aeruginosa showed positive metallo-β-lactamase profi le using double-disk combined method and combined E-test.
There is no trend of the dynamics and it is not possible to identify a model for forecasting a future change of the resistance to both antibiotics imipenem and meropenem for Pseudomonas and Acinetobacter in our ICU during the period 2010- Figure 1 . Antimicrobial resistance profi le of all A. baumannii and P. aeruginosa isolates included in the study. 2014. Nevertheless the levels of resistance still remain high -more than 76% for Acinetobacter and 43% for Pseudomonas for both carbapenems.
* Trimethoprim-sulfamethoxazole in Pseudomonas was tested for diagnostic purposes
The dynamics for the pointed period is shown in Fig. 2 . All A. baumannii isolates were subjected to PCR screening for the presence of OXA-23, OXA-24, OXA-58 and hyperexpression of OXA-51 due to upstream situated ISAba1. Forty two out of 43 (97.7%) were positive for OXA-23 (Fig. 4) . 100% correlation between the MHT results and the genetic screening was established. All isolates were negative for the presence of OXA-24, OXA-58 and hyper-expression of the intrinsic OXA-51.
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RAPD analysis of 21 random OXA-23 positive A. baumannii isolates from ICU, Cardiac Surgery and Burn-care Clinic revealed 6 RAPD types. The fi rst 11 types exhibited more than 90% similarity which suggests their common clonal lineage and the rest 10 profi les showed approximately 70% similarity which made us assumed they belong to a second clone (lines 1-11), (Fig. 5) . RAPD analysis of 20 random isolates P. aeruginosa from same departments revealed 3 RAPD types. All isolates Pseudomonas obtained from the ICU belonged to 2 similar RAPD profi les.
Sequencing analysis of 23 randomly chosen OXA-23 positive A. baumannii revealed 100% homology with the classical OXA-23 -ARI-1 gene described by Donald HM et al. 17 
DISCUSSION
This is the fi rst detailed molecular and phylogenetic study on the carbapenemases production in clinical isolates Pseudomonas and Acinetobacter from the largest Bulgarian hospital -St George University hospital in Plovdiv. The data obtained gave us grounds to assume that the leading cause for carbapenem resistance in our A. baumannii isolates was the presence of OXA-23 gene and respectively the production of carbapenemases. This was an expected result in view of that other Bulgarian authors published similar data concerning different University hospitals in the country. [18] [19] [20] Stoeva et al. organized the fi rst detailed study in our country on multi-drug resistant A. baumannii proving the wide spread of OXA-23 among them. OXA-58 and OXA-24 are not that signifi cant for Bulgaria as well as the hyperexpression of the intrinsic OXA-51 due to the upstream situated ISAba1. The latter is still not detected in Bulgarian A. baumannii isolates including ours. 18 The phylogenetic analysis of 21 OXA-23 positive A. baumannii in our study revealed the persistence of two main clones in the hospital. This correlates with the results from other Bulgarian hospitals. 18, [20] [21] [22] The RARD similarity profi les and same clone affi liation of ICU isolates suggests the co-existence of two strains. The slight genetic variability observed among clone isolates could be explained by the high selective antibiotic pressure in the ICU setting and the long period during which this clone was present. The persistence of one or two clones is not unusual for Bulgarian ICUs. 18, 21 It may predispose to nosocomial outbreaks.
No carbapenemase producing P. aeruginosa were detected in this study. Metallo-enzyme producing Pseudomonas are not typical for our country. The fi rst case of VIM-positive P. aeruginosa was published in 2008 by Keuleyan et al. 23 Since then till 2015 no other cases have been reported even though VIM and/or IMP encoding strains have been determined in all our neighbouring countries -Greece, Serbia, Romania and Turkey except Macedonia. [24] [25] [26] [27] [28] [29] In 2013 Vacheva et al. studied 29 Bulgarian clinical isolates of Pseudomonas aeruginosa in collaboration with the Medical University of Palma de Mayorca in Spain. 30 In this research they reported about the over-expression of MexXY-OprM and the loss of OprD receptor as a leading cause for carbapenem resistance. Furthermore our own investigations performed for fi rst time in our country proved that the leading factor for carbapenem resistance in our clinical P. aeruginosa isolates is the increased expression or hyperexpression of the MexXY-OprM effl ux pump as well. In some cases it was combined with increased expression or hyperexpression of MexAB-OprM with or without decreased or lost production of the OprD transmembrane receptor (unpublished data).
CONCLUSIONS
Carbapenem resistance is threatening tendency for severe therapeutic restrictions especially in the ICUs concerning the specifi city of services in these clinical units. The main cause determining such type of resistance for our hospital is the persistence of clonal-related OXA-23 producing A. baumannii strains, whereas in Pseudomonas the increased expression or hyper-expression of key effl ux pumps sometimes combined with decreased or lost production of OprD remains as a leading factor.
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